x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

South America ( XML Feed )
United States ( XML Feed )

Sep 13, 2016 1:22 PM ET

Archived: Rainforest Pharmacal: Company is developing and commercializing proprietary safe and highly efficacious drugs derived from unique plants of the Amazon rainforest

iCrowdNewswire - Sep 13, 2016

Rainforestpharmacalslogo

Rainforest Pharmacal

Company is developing and commercializing proprietary safe and highly efficacious drugs derived from unique plants of the Amazon rainforest.

Company Summary

 

The Company will identify and patent the active novel compound in a unique Amazon rainforest plant that has shown through extensive testing to be curative against brain, breast, prostrate, colorectal and luekemia cancers. Once the pre-clinical and clinical trials are perfrmed, the novel drug will be developed into internationally approved anti-cancer therapies. The world still has a great unmet need for curative, non-toxic oncology drugs.

 
  • StageProduct In Development
  • IndustryBiotechnology
  • LocationCheyenne, WY, US
  • CurrencyUSD
  • FoundedSeptember 2015
  • Employees3
  • WebsiteRainforestPharmacal.com

Team

  • Entrepreneur and owner of several companies. Served as the President of Global Pharmacal, Inc., a bio-pharmaceutical company located at the Texas Research Park in San Antonio, Texas. He has diverse skills including business start ups, development, marketing, sales and management. Masinter’s passion is to develop breakthrough therapies that will help people and will benefit shareholders.

     

     

  • Default avatar
    Thomas E. Williams, Ph.D,
    Chief Scientific Officer
    Unconfirmed

    Dr. Williams’ experience in the development of drugs for the treatment of cancer and hematologic malignancies spans more than 40 years: 22 years in pharmaceutical research and 20 in academia. In 1979, he joined Burroughs Wellcome Company where he served in various positions culminating as the Head of the Section of Oncology. In 2008, he co-founded Thistle Advisors International to provide oncology consultation for the pharmaceutical industry.

Contact Information:

Charles Mazinter

View Related News >